MK-0893

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Diabetes Mellitus, Type 2Type 2 Diabetes Mellitus

Phase 2

A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015)

CompletedNCT00631488

Merck Sharp & Dohme LLCDiabetes Mellitus, Type 2

Start: 2008-02-29End: 2009-01-31Updated: 2017-01-02

A Study to Assess the Safety, Tolerability and Glucose-Lowering Efficacy of MK-0893 in Participants With Type 2 Diabetes Mellitus (MK-0893-005)

CompletedNCT02004886

Merck Sharp & Dohme LLCType 2 Diabetes Mellitus

Start: 2006-08-11End: 2007-02-07Updated: 2018-09-05